Company Filing History:
2 out of 2 
1 out of 4 Years Active: 2014-2025
Title: Diego Moricoli: Innovator in Antibody Complexes
Introduction
Diego Moricoli is a notable inventor based in Fano, Italy. He has made significant contributions to the field of biotechnology, particularly in the development of antibody complexes. With a total of 2 patents, Moricoli's work focuses on innovative solutions for medical diagnostics and treatments.
Latest Patents
Moricoli's latest patents include an "Antibody complex and uses thereof." This invention pertains to a multivalent, preferably bivalent, antibody complex capable of recognizing and binding the human protein CD99. The composition is intended for diagnostic purposes and for the treatment and follow-up of leukaemias and myelodysplastic syndromes. Additionally, he has developed antibodies, preferably monoclonal, of the immunoglobulins G group type that can recognize and bind the human protein CD99, with medical applications for treating solid tumors and leukaemias. Another significant patent is for "Antibody derivatives," which describes an anti-CEA scFv that is surprisingly stable and highly specific for CEA and CEACAM1.
Career Highlights
Throughout his career, Diego Moricoli has worked with various organizations, including Diatheva S.r.l. and the Istituto Superiore Di Sanità. His expertise in antibody technology has positioned him as a key player in the biotechnology sector.
Collaborations
Moricoli has collaborated with notable professionals in his field, including Valentina Fiori and Maurizio Cianfriglia. These partnerships have contributed to the advancement of his research and innovations.
Conclusion
Diego Moricoli's contributions to the field of biotechnology, particularly through his patents on antibody complexes, highlight his role as an influential inventor. His work continues to impact medical diagnostics and treatment options for various diseases.